bacteria in the gut outnumber the cells of the host by two orders of magnitude. Although labeled " commensal, " these bacteria (and other microorganisms) do more than to simply " share our table. "
The gut microbiota are absolutely required for normal host function. Intestinal bacteria provide necessary enzymes for the digestion and fermentation of certain nutrients and nondigestible dietary residues; synthesize important vitamins; metabolize dietary carcinogens; participate in the processing of endogenously derived mucus; help with ion absorption and the salvage of energy; and control epithelial cell proliferation. In addition, commensal bacteria participate in protection against intestinal pathogens. Th ey occupy important ecological niches and compete with ingested pathogens for nutrients; they strengthen the epithelial barrier and occupy epithelial cell adhesion receptors, decreasing the invasive capacity of pathogens; they produce ligands that activate pattern recognition receptors, for example, Toll-like receptors, resulting in secretion of host bactericidal substances such as anti-microbial peptides and in immunostimulatory signals that help recruit B and T cells in the lamina propria, organize secondary lymphoid structures, and induce IgA secretion into the lumen; and they secrete molecules, such as lactic acid, that inhibit the growth of competing microorganisms. Th us, the intestinal microbiota represent an integral and vital part of the host organism and are therefore referred to as the " microbial organ. "
Th e aforementioned functions of the microbial organ could be considered as general properties of established microbial communities, which can be carried out by a large number of bacterial taxons. However, how the composition of Th e main function of the immune system is to recognize foreign antigens and to initiate responses appropriate for the off ending microorganisms. Th e mucosal immune system, however, faces unique challenges due to the nature of the foreign antigens that it encounters. Although pathogenic microorganisms need to be neutralized, they represent only a small fraction of the intestinal antigenic load. Most intestinal antigens consist of food substances and large numbers of resident bacteria, known as commensal microbiota, which must be tolerated because their presence is necessary for the normal function of the organism. Food antigens are crucial for survival and induce oral tolerance. Commensal bacteria, similarly, have an integral part in host metabolism, physiology, and immunity, and thus need to be preserved.
Th e knowledge that microorganisms are present in our bodies is as old as the study of microbiology itself. Approximately 350 years ago Leeuwenhoek visualized the fi rst bacteria by examining samples from his oral cavity and feces noting in his letters to the Royal Society of London that in the scurf of a man ' s teeth, " there might have been 1000 in a quantity of matter no bigger than 1 / 100 part of sand. " We now know that resident the microbiota affects host metabolic and immune functions has remained relatively unexplored. Pioneering studies from Jeff Gordon ' s group showed the importance of the repertoire of commensal taxons in modulating host metabolism and energy uptake by identifying an obesity-associated microbiome. 1 Changes in the representation of bacterial groups have also been described in infl ammatory bowel disease patients and in mouse colitis models, and there have been eff orts to identify an infl ammatory bowel disease-associated microbiome. Th ese and other studies have led to the hypothesis that shift s in the composition of intestinal communities may contribute to disease, and that preventing such changes or antagonizing the relevant mechanisms may lead to new therapies.
Similarly, shifts in the composition of the microbiota may modulate the mucosal immune balance at steady state, thereby strengthening immune responses against intestinal pathogens. How specifi c commensals fulfi ll this role has received little attention. Recently, however, the human commensal, Bacteroides fragilis , was shown to induce the maturation of systemic Th 1 and intestinal regulatory responses following colonization of germfree (GF) mice, through the production of unique types of polysaccharide A. 2, 3 Th e presence of B. fragilis induced IL-10-mediated protection from colitis initiated by Helicobacter hepaticus infection. 3 Further, we recently discovered that the composition of the intestinal microbiota can profoundly aff ect the balance between IL-17-producing eff ector T helper (Th 17) cells, which sustain mucosal immune responses, and Foxp3 + regulatory T cells, which downregulate excessive infl ammation in the lamina propria. 4 Commensal bacteria were required for induction of Th 17 cells, as these cells were absent in GF animals. At the same time, GF mice possessed higher proportions (although not total numbers) of Foxp3 + Tregs than conventionally raised animals. Introduction of wild-type microbiota into GF mice reversed the ratio between Th 17 and Treg cells. Most importantly, colonization of GF mice with microbiota isolated from diff erent colonies of conventionally raised mice had diff erent eff ects on the Th17:Treg balance. Colonization with microbiota from Taconic C57BL / 6 (B6) mice induced robust Th 17 cell diff erentiation and decreased Treg percentages. In contrast, colonization with Jackson B6 microbiota led to only a modest increase in the proportion of Th 17 cells and did not aff ect Treg percentages. Th e eff ects of the microbiota on Th17 cell induction were independent of the presence of any single known microbe-associated molecular pattern pathway. 4 In addition to suggesting the existence of a Th 17 cellinducing component of the microbiota, these studies for the fi rst time showed that the nature of the pre-existing mucosal T-cell response in the same host can be modulated by the composition of intestinal bacteria. Together, all these results suggest that it may be possible to target the mechanisms of specifi c commensalhost interactions to modulate mucosal immune responses for therapeutic purposes.
With the goal of identifying such interactions, we compared the composition of microbiota of Taconic and Jackson B6 mice. 5 We aimed to identify Th 17 cell-inducing commensal bacteria and therefore concentrated on bacterial taxons that were overrepresented in the Taconic microbiota. Notably, the differences between the two colonies did not cluster to specific phyla, but were represented as individual taxons across diverse bacterial classes, indicating that in addition to general microbe-associated molecular patterns, products of individual bacteria may be important for the function of the microbial organ. One member, segmented fi lamentous bacteria (SFB), was abundant in Th 17 cell-sufficient Taconic B6 mice, but absent in Th 17 cell-defi cient Jackson B6 mice. SFB were described more than 40 years ago as commensals in a number of mammalian and insect species. Th ey are currently defi ned by their unique morphology and by recently developed specifi c DNA probes. Th e SFB 16S rRNA gene sequence is most closely related to Clostridia , although proper classifi cation awaits the genomic sequence of this organism. SFB have been associated with a number of immunostimulatory functions and appear in the small intestine aft er weaning. Studies of SFB biology have been hampered by the current absence of ex-vivo culture methods. Nevertheless, SFB can be propagated as a pure culture by monocolonization of GF mice. Th e most intriguing feature of SFB is their close interaction with epithelial cells in the terminal ileum and their intimate cross talk with the host immune system. 6,7 SFB were present only in mice that had Th 17 cell-inducing microbiota, including Taconic B6 mice. In contrast, they were not detected in mice that lacked Th17 cells owing to absence of Th17 cell-inducing microbiota, such as Jackson B6 mice or Taconic B6 mice treated with Th 17 cell-depleting antibiotics. 5 In Taconic B6 mice, the SFB formed a network of segmented fi laments in the terminal ileum and were attached to the villous epithelium ( Figure 1 ).
To test whether SFB are suffi cient to induce Th 17 cell diff erentiation, we colonized GF mice as well as SFB-defi cient Jackson B6 mice with fecal material from SFB-monocolonized gnotobiotic mice. This treatment, but not colonization with a number of other commensal bacteria, including closely related Clostridia , induced IL-17 and IL-22 production by CD4 + T cells. SFB colonization specifi cally induced Th 17 cells, as it did not aff ect the proportion of IFN + Th 1 or Foxp3 + Treg cells. 5 Th erefore, SFB represent the fi rst example of a commensal bacterium that specifi cally induces an eff ector helper T cell population in the intestinal mucosa. Th e Th 17 cell inductive capacity of SFB was confi rmed by two other studies. 7, 8 One study, reported a more general immunostimulatory capacity for SFB, illustrated by relative increases in IFN + and CD25 + Foxp3 + cells in the intestine. 8 Th ese discrepancies may be due to the diff erent source of SFB or may suggest a dependence of the SFB eff ect on the host, as the studies were performed in diff erent mouse strains. At the same time, they may be explained by the increase in the total number of CD4 + T cells in the gut aft er SFB colonization. 4, 8 Indeed, more careful examination of the data shows that although SFB colonization recruits T cells in the lamina propria, which leads to a general increase in T cell activation markers, there does not seem to be a proportional increase in IFN + or Foxp3 + cells in the CD4 + T cell subset. 8 Th us, SFB very specifically aff ect the proportion of Th 17 cells and can potentially skew the balance of mucosal eff ector T cell responses.
What, then, is the functional consequence of the presence of SFB in the commensal microbiota? To address this question, we examined the changes in gene expression in the terminal ileum following colonization with SFB. Genes specifi cally induced by SFB, but not other commensals, were enriched in immune, inflammatory, and defense response pathways. 5 Among the most highly upregulated genes were those encoding a number of epithelial cell-derived anti-microbial peptides, such as Reg III . Reg III is a bactericidal C-type lectin that is induced by commensal bacteria and by IL-22 and provides protection in the lumen from intestinal infections. 9 We therefore hypothesized that colonization with SFB may bolster mucosal immunity through the induction of Th 17 cells, IL-22, and anti-microbial peptides. To directly test this hypothesis, we challenged SFB-colonized and control mice with Citrobacter rodentium , an intestinal pathogen whose clearance requires Th 17-related molecules such as IL-23, IL-22, as well as Reg III . 9 SFB-colonized mice were better protected from infection, as indicated by reduced colon mucosa thickness, as well as a reduced C. rodentium titer recovery from the colonic wall. 5 Th us, SFB mediate mucosal protection through the induction of specifi c host immune mechanisms.
Our results constitute the fi rst evidence that a specifi c commensal bacterium can induce a defi ned CD4 + eff ector T cell population in the gut mucosa. Th us, the composition of the gut microbiota can modulate or predetermine the nature of the immune response of the host and aff ect protective immunity upon infection. In the case of SFB, this leads to an increase in the relative proportions of Th 17 cells and Th 17 cell cytokines, which provide protection against mucosal infection. The flipside is the generation of potentially harmful proinflammatory . This changes the immunological fitness of the individual. In the case of SFB, the increased production of Th17 cell effector cytokines, for example, IL-17 and IL-22, and the consecutive increase in anti-microbial peptide production from epithelial cells (blue circles) augments the ability of the host to fight off intestinal infections. At the same time, this increase in proinflammatory cytokines may render the host more susceptible to chronic autoimmune inflammation. In this way, differences in the repertoire of commensal bacteria between the individuals of the same species may account for differences in the nature and robustness of their response in the face of similar environmental challenges.
cytokines. Therefore, SFB-mediated changes may increase the risk of autoimmune infl ammation in susceptible hosts ( Figure 2 ).
Fine tuning of intestinal immune responses by the presence or absence of certain members of the microbiota opens the exciting possibility of directionally modulating these responses by either changing the composition of the gut bacteria or modifying relevant signaling pathways to increase resistance to infection or decrease susceptibility to infl ammatory bowel diseases and other infl ammatory diseases. Th erefore, it will be crucial to elucidate the molecular mechanisms by which commensals, such as SFB, infl uence mucosal responses.
Th e specifi c eff ect of SFB on the homeostasis of intestinal eff ector T cell populations is not likely to be an isolated event. On one hand, other commensals with Th17 cell-inducing capacity may exist. For example, SFB-defi cient Jackson microbiota induce low levels of Th 17 cells upon transfer into GF animals, and the existence of non-SFB ATP-producing microbiota that induce Th17 cells has been reported. 5, 10 On the other hand, other members of the microbiota may skew immune homeostasis in diff erent directions. For example, although colonization of GF mice with total intestinal microbiota both induced Th 17 cell diff erentiation and decreased the proportions of Foxp3 + Tregs, colonization with SFB only aff ected Th 17 cell numbers. 4, 5 Th erefore, other microbiota entities may be involved in regulating Treg proportions or function. Identifi cation of more examples of immunomodulatory interactions between individual commensal species and the host, and the underlying mechanisms, promises new and exciting ways to modulate intestinal immune responses for therapeutic purposes.
